On April 4–5, 2025, the Center of Research Excellence Management Unit (SiCORE-M) had the great honor of hosting its Annual Seminar: Retreat 2025 at the Howard Johnson by Wyndham Pattaya JC Hotel, Chonburi Province. The event was presided over by Professor Apichat Asavamongkolkul, M.D., Dean of the Faculty of Medicine Siriraj Hospital, who served as […]

On January 21, 2025, the executive team from the Faculty of Medicine Siriraj Hospital, led by Dean Professor Apichat Asavamongkolkul, along with Deputy Dean for Research and Innovation, Assoc. Prof. Sith Sathornsumetee, Head of the Center of Research Excellence (SiCORE-M), and Assistant Professor Woraphat Ratta-Apha visited the SiCORE-DO center at the SiMR Building. The SiCORE-DO team warmly welcomed the executive team, represented by Prof.Nattachet Plengvidhya, the Director, and his SiCORE-DO team members.

During the visit, the SiCORE-DO team presented key achievements and an operational progress report, highlighting advancements in diabetes and obesity research. The session fostered valuable discussions on strategic initiatives and future directions, reinforcing our unwavering commitment to driving impactful research and innovation in metabolic diseases. This commitment is a beacon of inspiration, guiding our collective efforts toward a healthier future.

We are thrilled to announce that our latest research on enhancing the immune system’s ability to combat cholangiocarcinoma (bile duct cancer) has been accepted for publication in Biomedicine & Pharmacotherapy (Impact Factor: 6.9)! 🎉

Led by researchers at the Siriraj Center of Research Excellence for Systems Pharmacology (SiSP) in collaboration with expert partners, this study uncovers a promising strategy to restore immune function in this highly aggressive cancer. By reactivating the body’s natural defenses, this approach brings new hope for more effective treatments.

🔬 Read the full research highlight here: https://www.sisyspharm.org/highlights/reactivating-the-bodys-natural-defenders-a-new-hope-for-fighting-cholangiocarcinoma